Artenimol
Specifications
71939-50-9CAS Number
615-698-8EC Number
(1R,4S,5R,8S,9R,10S,12R,13R)-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecan-10-olIUPAC Name
C15H24O5Chemical Formula
284.35 g/molMolecular Weight
Artenimol; Cotexin; Alaxin; Cotecxin; Dihydroartemisinine; Dihydroqinghaosu; Salaxin; Santecxin; Dynamax; Di-hydroqinghaosu; Artenimolum; GNF-PF-5634; beta-Dihydroartemisinin; 6A9O50735X; Dihydroquinghaosu; EURARTESIM COMPONENT DIHYDROARTEMISININ; (1R,4S,5R,8S,9R,10S,12R,13R)-1,5,9-Trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecan-10-ol; (3r,5as,6r,8as,9r,10s,12r,12ar)-decahydro-3,6,9-trimethyl-3,12-epoxy-12h-pyrano[4,3-j][1,2]benzodioxepin-10-ol; quinghaosu, dihydro-; artemisinin, dihydro-; (1R,4S,5R,8S,9R,10S,12R,13R)-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo(10.3.1.04,13.08,13)hexadecan-10-ol; (3r,5as,6r,8as,9r,10s,12r,12ar)-decahydro-3,6,9-trimethyl-3,12-epoxy-12h-pyrano(4,3-j)(1,2)benzodioxepin-10-ol; (3R,5aS,6R,8aS,9R,10S,12R,12aR)-Decahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano(4,3-j)-1,2-benzodioxepin-10-ol; I2-dihydroartemisinine; RefChem:114268; DIHYDROARTEMISININ, BETA-; P01BE05; (1S,4S,5R,8S,9R,10S,12R,13R)-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo(10.3.1.04,13.08,13)hexadecan-10-ol; dihydroquinghaosu, (3R-(3alpha,5abeta,6beta,8abeta,9alpha,10alpha,12alpha,12aR*))-; (1R,4S,5R,8S,9R,12R,13R)-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo(10.3.1.04,13.08,13)hexadecan-10-ol; Dihydroartemisinin; 71939-50-9; Dihydro Artemisinin; 81496-82-4; .beta.-dihydroartemisinin; Dihydroartemisinin, .beta.-; Artenimol [INN]; DHQHS 2; (3R,5aS,6R,8aS,9R,10S,12R,12aR)-3,6,9-trimethyldecahydro-12H-3,12-epoxy[1,2]dioxepino[4,3-i]isochromen-10-ol; 3,12-Epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin-10-ol, decahydro-3,6,9-trimethyl-, (3R,5aS,6R,8aS,9R,10S,12R,12aR)-; CHEMBL307261; ?-dihydroartemisinin; MFCD00274495; ARTENIMOL [USAN]; ARTENIMOL [MART.]; ARTENIMOL [WHO-DD]; ARTENIMOL [WHO-IP]; DIHYDROARTEMISININ [MI]; GTPL9957; orb1224154; orb1310451; SCHEMBL17156483; BJDCWCLMFKKGEE-ISOSDAIHSA-N; CHEBI:135921; DTXSID501021652; GLXC-07598; ARTENIMOLUM [WHO-IP LATIN]; DIHYDROARTEMISININ [USP-RS]; DIHYDROARTEMISININ [WHO-DD]; HY-N0176; MSK163132; AKOS032949625; CS-5595; FD11674; SY058680; A6979; NS00071253; A11600; EN300-7419972; Dihydroartemisinin,mixture of alpha and beta isomers; BRD-K62213621-001-01-6; (1R,4S,5R,8S,9R,10S,12R,13R)-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.0^{4,13}.0^{8,13}]hexadecan-10-ol; (3R,5?S,6R,8?S,9R,10S,12R,12?R)-Decahydro-3,6,9-trimethyl- 3,12-epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin-10-ol; (3R,5aS,6R,8aS,9R,10S,12R,12aR)-3,6,9-trimethyldecahydro-3,12-epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin-10-ol; (3R,5aS,6R,8aS,9R,12S,12aR)-octahydrogen -3,6,9-trimethyl -3,12-epoxy -12H-pyrane [4,3-j]-1,2-coumaron -10 ( 3H ) alcoholSynonyms
Products Containing Artenimol
말락신정(디하이드로아르테미시닌, 피페라퀸포스페이트)(수출용)마렉신정120밀리그람(디히드로아르테미시닌)(수출용)마렉신정,말톱정,마톱정,맥신정,잘라정,마판정(디히드로아르테미시닌)(수출용)EURARTESIM 320 mg/ 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULAEURARTESIM 320 mg/40 mg, comprimé pelliculéDihydroartemisininDihydroartemisininDIHYDROARTEMISININ FOR ORAL SUSPENSIONDihydroartemisininDihydroartemisinin
